Perfluoropentanoic acid weighs 264 Daltons. Perfluorobutanoic acid weighs 214. Perfluorobutane sulfonate weighs 300. Perfluorohexanoic acid weighs 314. Each of these molecules is a short-chain per- or polyfluoroalkyl substance -- the class of fluorochemistry the textile industry moved to after restricting the longer-chain compounds. Each sits inside a boundary the pharmaceutical industry has respected for twenty-five years: compounds below approximately 500 Daltons passively cross human skin.1
That boundary is not a guideline. Bos and Meinardi published it in Experimental Dermatology in 2000, grounded in three independent empirical patterns: virtually all common contact allergens are below 500 Da; all commonly used topical dermatotherapy agents are below 500 Da; and all known drugs used in transdermal drug-delivery systems are below 500 Da.1 The rule is the design constraint for every nicotine patch, every fentanyl patch, every hormone-replacement system on the market. What is smaller than 500 Daltons can cross the stratum corneum -- the outermost layer of skin that functions as the body's primary chemical barrier. What is larger, generally, cannot.
The industry's substitution of long-chain PFAS (PFOA at 414 Da, PFOS at 500 Da) with short-chain replacements did not move the chemistry out of that window. It moved the chemistry deeper in.
The Specification
Transdermal drug patches are engineered around five enhancer variables that maximise the rate at which a molecule crosses skin. Performance activewear, worn during exercise, supplies all five.
| Enhancer Variable | Transdermal Drug Patch | Compression Activewear During Exercise |
|---|---|---|
| Occlusion | Sealed backing raises stratum corneum hydration and disrupts barrier lipids2 | Compression knit + synthetic yarn + tight fit approximates occlusion against skin |
| Elevated skin temperature | Body heat warms the patch site to 34--37 C | Exercise raises skin temperature to 34--38 C across working-muscle zones |
| Increased cutaneous blood flow | Vasodilator excipient or body heat | Active vasodilation during exercise increases cutaneous blood flow many times above resting baseline, reaching 6--8 litres per minute under whole-body heat stress3 |
| Carrier / wetting agent | Adhesive matrix with solvent vehicle | Sweat -- a polar carrier with surfactant-like electrolytes, produced at 0.5--2.0 litres per hour during moderate exercise |
| Extended contact duration | 12--72 hours per patch application | 1--3 hours per session; a daily cyclist or yoga instructor wears compression garments 15--30 hours per week |
Nothing in this table is metaphor. Each row is a measured variable from one literature placed beside a measured variable from another. The two literatures -- transdermal pharmacology and exercise physiology -- have not been held against each other in peer-reviewed print. No peer-reviewed study bridging these two literatures was identified.
This report introduces a term for the object standing in the middle: the Unregulated Transdermal Patch -- the class of consumer garments whose combination of material architecture, fit geometry, and use-context supplies five or more of the enhancer variables used in commercial transdermal drug patches while carrying sub-500-Da bioactive fluorochemistry that is not regulated, tested, or disclosed as a transdermal delivery system. The term is a structural description of a class. It is not a medical claim about any specific product.
The class has boundaries. A cotton t-shirt worn for a gym session supplies duration, partial occlusion, and sweat carrier but carries no DWR fluorochemistry -- it falls outside the class. Compression tights used as loungewear supply duration and occlusion but minimal vasodilation and minimal sweat -- three or fewer enhancer variables; outside the class. A merino-wool hiking baselayer supplies duration, contact, and sweat but no fluorinated finish -- outside the class. What qualifies is the intersection: compression fit, DWR-treated synthetic knit, exercise-intensity physiological state, and multi-hour contact.
The Chemistry Inside the Claim
The fluorochemistry in finished performance activewear today includes GenX (HFPO-DA, 330 Da), PFHxA (314 Da), PFBS (300 Da), 6:2 fluorotelomer alcohol (6:2 FTOH, 364 Da), and side-chain fluorinated polymers (SFPs) used as durable water-repellent binders. The C8-to-C6-to-C4 trajectory is documented: as regulatory pressure forced the phase-out of PFOA and PFOS, manufacturers substituted shorter-chain molecules from the same chemical class.4 The peer-reviewed literature calls this "regrettable substitution."5 Each step shortened the carbon chain. Each step lowered the molecular weight. Under the Bos rule, each step moved the replacement deeper into the passive-crossing window.
Ragnarsdottir, Abdallah, and Harrad at the University of Birmingham tested 17 PFAS for dermal bioavailability in 2024, using in-vitro 3D human skin equivalent models with a methanol carrier at a dose of 500 ng/cm-squared over 24--36 hours.6 PFPeA absorbed at 58.9%. PFBS absorbed at 48.7%. PFOA -- the longer-chain molecule the industry was moving away from -- absorbed at 13.5%, with a further 38% retained in the skin. The correlation between chain length and absorbed fraction was inverse and strong: r = 0.97 for perfluorocarboxylic acids and r = 0.97 for perfluorosulfonic acids against logKOW.6 Shorter chain, more crosses.
The substitution did not resolve the dermal question. The substitution inverted it.
The Body Pathway
Entry. The stratum corneum is roughly 15--20 micrometres thick. Below it lies the viable epidermis, then the dermis, then the capillary bed. During exercise, active vasodilation opens cutaneous blood flow to as much as 6--8 litres per minute under whole-body heat stress -- up to roughly thirty times the resting baseline of approximately 0.25 litres per minute.3 Sweat delivers a polar solvent directly to the skin surface. Compression fabric seals against the body, reducing ventilation and raising stratum corneum hydration -- the same barrier-disruption mechanism that occlusion achieves in a transdermal patch.2 Sub-500-Da fluorochemistry crosses the stratum corneum's intercellular lipid domains and enters the dermis.
Travel. Once past the stratum corneum, short-chain perfluoroalkyl acids enter the dermal capillary bed and distribute via the bloodstream. They are not metabolised by the body -- the carbon-fluorine bond is among the strongest in organic chemistry, and mammalian enzyme systems do not break it efficiently. The compounds reach the liver and kidneys, the primary organs of distribution and excretion.
Accumulation. Short-chain PFAS do not bioaccumulate in the way long-chain PFAS do. PFBA has a serum half-life of approximately 3 days.7 PFPeA clears rapidly, though its human serum half-life has not been reliably established -- the compound is frequently below detection limits in biomonitoring studies, preventing precise estimation.7 PFHxA persists for roughly 32 days, based on elimination kinetics measured in occupationally exposed ski wax technicians.7a PFBS has a measured human serum half-life of approximately 26 days.7b These are rapid turnovers compared to PFOA (2--8 years) or PFOS (3--7 years).7 But the relevant frame is not single-dose clearance. A person wearing DWR-treated compression leggings five mornings a week does not clear the dose from Tuesday before Thursday's session. Under continuous exposure, the body burden is maintained at steady state by ongoing intake. The chemistry clears. The exposure does not. A plateau, sustained by the next session.
Zheng, Eick, and Salamova measured PFAS concentrations across dust, drinking water, serum, and urine in 81 US participants and their homes. Ultrashort- and short-chain PFAAs constituted 69--100% of total PFAA concentrations across all four matrices.8 The molecules Harrad measured crossing skin in vitro are the same molecules dominating population-level biomonitoring. Zheng's study attributes the exposure pathways to dust ingestion and drinking water -- not dermal contact. The pathway-specific attribution remains open. What is established is class congruence: the molecules entering skin in the laboratory are the molecules found in blood in the field.
Harm. The health significance of PFAS exposure is not in dispute at the regulatory level. The European Food Safety Authority set a tolerable weekly intake of 4.4 ng/kg body weight per week for the sum of PFOA, PFNA, PFHxS, and PFOS, based on reduced antibody response to vaccination -- an immune-system endpoint derived from the Faroe Islands birth cohort studied by Grandjean and colleagues.910 That TWI is a food-exposure value; dermal uptake is additional to the dietary envelope it was derived from, not measured against it.
The C8 Science Panel -- a court-ordered independent study of 69,030 Mid-Ohio Valley residents exposed to PFOA from industrial contamination -- found "probable links" between PFOA exposure and six health endpoints: kidney cancer, testicular cancer, ulcerative colitis, thyroid disease, high cholesterol, and pregnancy-induced hypertension.11 [epidemiological, human cohort] The US Agency for Toxic Substances and Disease Registry's 2021 Toxicological Profile identifies developmental, immune, hepatic, thyroid, and reproductive endpoints across the PFAS class.7 ATSDR's own assessment of dermal exposure is a single sentence: "Although not well studied, the available absorption data suggest that dermal contact may also contribute to the overall perfluoroalkyl body burden."7
The federal hazard-reference agency acknowledges the pathway. It declines to quantify it.
Timeline.
TIMELINE OF PERSISTENCE
- Use-life of compression leggings: 2--5 years
- Serum half-life of PFBA: approximately 3 days
- Serum half-life of PFHxA: approximately 32 days
- Serum half-life of PFOA: 2--8 years
- Environmental half-life of short-chain PFAS: decades to indefinite
- Time since Mamavation detected fluorine in branded activewear: 1,546 days (2022-01-18 to 2026-04-13)
- Time since any independent party published a study measuring dermal uptake from worn activewear during exercise: no such study identified as of April 2026
The Zone Overlap
Activewear is not finished uniformly. DWR is applied at the textile mill by foulard pad or knife-over-roll coating. Outer-facing panels -- the surfaces where water beading is tested by quality control -- receive heavier finish loads. Through-fibre migration during the curing process deposits fluorochemistry on both faces of the knit, including the skin-contacting face.
Smith and Havenith at Loughborough University mapped regional sweat rates during exercise. In moderately trained women cycling at 60% VO2max, the highest regional sweat rates were central upper back (223 g/m-squared/h), between the breasts (139 g/m-squared/h), and dorsal foot (139 g/m-squared/h).12 Core-trunk skin blood flow rises faster than extremity blood flow during thermal stress.3
The panels that receive the heaviest water-management finish cover the zones of highest sweat rate and vasodilation. The garment works at those zones because those zones shed the most moisture. The chemistry is densest where the barrier is thinnest.
A "PFAS-free" test on a single swatch does not answer the question for the waistband, the gusset, or the central back panel.
The Polymer Exemption That Is Already Failing
Most PFAS restriction frameworks -- including the EU universal PFAS restriction's draft derogations -- treat polymer-bound fluorine as chemically inert and therefore bioinaccessible. Side-chain fluorinated polymers used in DWR coatings are exempted on this assumption. The assumption holds at time zero. It does not hold across a garment's service life.
Schellenberger and colleagues at Stockholm University exposed SFP-coated polyamide textiles to six months of outdoor aging on a Sydney rooftop. PFOA concentrations in C8F17-treated fabric rose from 12 ng/g to 513 ng/g -- a 43-fold increase that exceeded the EU regulatory threshold of 25 ppb by 20 times.13 The tested substrates were DWR-treated polyamide outerwear shells, not compression knit activewear. The polymer-exemption regulatory logic, however, operates at the chemistry-class level: it does not distinguish between fluorinated polymer on a jacket shell and fluorinated polymer on a sports bra. The exemption is class-wide. The refutation is class-wide.
Van der Veen and colleagues at VU Amsterdam measured 6:2 FTOH concentrations in aged FC-6 coated polyamide before and after five standard wash cycles. The concentration rose from 87 micrograms per kilogram to 430 -- a 4.9-fold increase.14 What was not extractable from the polymer at the factory became extractable under conditions the garment meets in the consumer's home.
The OECD's 2022 synthesis confirmed the pattern across independent studies: side-chain fluorinated polymers function as precursors, hydrolysing and oxidising into short-chain perfluoroalkyl acids over time.15 The assumption that underwrites the exemption is refuted by the regulatory body's own scientific reference.
The fibre that touches skin at wash 30 is not the fibre that left the factory.
The Three Tests That Cannot See Each Other
"PFAS-free" is a claim. The claim rests on a test. The test is one of three, and each is blind to what the others catch.
| Test Method | What It Measures | What It Misses |
|---|---|---|
| Total Fluorine (TF) -- OEKO-TEX 2024 (100 mg/kg, reducing to 50 mg/kg in 2026); California AB 1817 TOF variant (100 ppm from 2025, 50 ppm from 2027) | Elemental fluorine via combustion and ion chromatography | Catches PFAS and non-PFAS fluorinated compounds (dyes, finishes). Cannot distinguish which fluorine is from PFAS. |
| Extractable Organofluorine (EOF) | Fluorine extractable by solvent | Misses polymer-bound fluorine entirely -- the fraction Schellenberger and van der Veen showed becomes extractable over service life. |
| Targeted PFAS List -- EPA Method 1633, most brand restricted-substance lists | 30--40 specific PFAS molecules via LC-MS/MS | Misses every PFAS not on the list. The list is always historical. GenX, PFHxA, and 6:2 FTOH-acid were invisible to pre-2018 targeted methods. |
Lululemon's Restricted Substances List (RSL 9.0, released October 2024) caps total organic fluorine at 50 ppm.16 The RSL does not publicly disclose which measurement method is specified, what detection limit is required, or whether testing applies to finished garments or fabric rolls. Without those three disclosures -- method, list, detection limit -- the consumer cannot evaluate the claim against any jurisdiction's threshold. The claim is a compliance statement. It is not a measurement the consumer can trace.
The Inversion
The coating that repels water also repels the regulatory measurement that would tell you what sits underneath it. The test that would resolve the question -- dermal uptake from a worn compression garment during exercise, using synthetic sweat as carrier, at elevated skin temperature, under occlusion, over multiple hours -- has not been run. No commercial stakeholder has funded it. No regulatory body has required it.
Pre-Existing Evidence
On 18 January 2022, Environmental Health News and Mamavation published testing results from an EPA-certified laboratory on 32 pairs of women's activewear. Eight showed detectable organic fluorine, at concentrations ranging from 10 to 284 ppm.17 The Silent Spring Institute, in a separate study the same year, found fluorine in 54 of 93 children's and textile products -- 58% of the sample. The authors found that targeted PFAS were detected "only in products labeled as water- and/or stain-resistant," regardless of whether they carried green or nontoxic marketing claims.18 [independent testing, EPA-certified lab]
This investigation continues below.
Want the next one in your inbox?
The Texas Attorney General's civil investigative demand against Lululemon was filed on 13 April 2026 -- 1,546 days after the Mamavation results were published.19 The chemistry signal was testable by consumer-journalism infrastructure in 2022. What changed in 2026 was the format: a state enforcement authority converted the signal into institutional language. The evidence was the same. The register was different.
Lululemon's corporate statement, preserved in its exact language: "lululemon does not use PFAS in products today." The company further states: "Our ongoing focus is to help prevent the unintentional reintroduction of PFAS into our products" and "We require all our vendors to regularly conduct testing for restricted substances, including PFAS, by credible third-party agencies to confirm ongoing compliance."20 Three hedges are stacked: temporal ("today"), volitional ("does not use" -- silent on what is physically present from supply-chain carry-over), and vendor-offloaded (unnamed labs, undisclosed methodology and detection limit). This pattern is not unique to any one company. It is a feature of present-tense restricted-substance language across the activewear category. Jurisdictional enforcement of such claims is the territory of the second report in this series.
The Counter-Position
Four defences are available to industry. Each covers something real.
"The Harrad study used methanol, not sweat." Correct. Methanol is a penetration enhancer; it accelerates transport through skin in ways that sweat does not. The 58.9% PFPeA absorption measured by Harrad and colleagues was obtained in a 3D human skin equivalent model, with a methanol vehicle, at ambient temperature, under static conditions.6 That measurement is the only quantified value that exists. The variables methanol omits -- elevated skin temperature, active vasodilation reaching up to 6--8 litres per minute under heat stress, mechanical friction, multi-hour occluded contact, sweat as polar carrier -- each act in the direction of increased transdermal permeation under the established physics of dermal pharmacology. Direction is upward; magnitude is unknown. The study that would resolve the magnitude has not been funded.
"The dose makes the poison -- fabric concentrations are below regulatory thresholds." The regulatory thresholds in force (OEKO-TEX total fluorine at 100 mg/kg; California AB 1817 at 100 ppm TOF; EU PFHxA at 25 ppb targeted) are concentration-in-fabric thresholds. They measure what is in the textile. They do not measure what crosses into the body. No threshold currently in force accounts for vasodilation, occlusion, sweat carrier, skin temperature, or multi-hour contact duration. The dose makes the poison -- granted. But the dose everyone measures is the dose in the fabric. The dose the body receives has not been measured. And the dose the body receives adds to a tolerable weekly intake of 4.4 ng/kg body weight already at or near saturation from dietary sources in significant sub-populations.9
"Industry is moving to C0 fluorine-free DWR." Patagonia announced in 2025 that 100% of new products are made without intentionally added PFAS, noting publicly that fluorinated finishes tend to last longer through abrasion and multiple washes while fluorine-free DWRs require more frequent reactivation.21 The transition is real and directionally correct. It does not address the millions of garments in current service, treated with C6/C8/SFP chemistries, approaching the wash-cycle range where polymer-bound fluorine becomes extractable. And C0 garments require more frequent laundering to maintain performance, multiplying the number of wash cycles the consumer runs.
"Total fluorine is not PFAS -- the tests catch false positives." Correct. Total fluorine screens detect all fluorinated compounds, including non-PFAS dyes and finishes. The method is overinclusive in one direction and underinclusive in another: extractable organofluorine misses polymer-bound fluorine; targeted lists miss every molecule not on the list. No single method can see the whole picture. "PFAS-free" rests on whichever single method the brand selected.
Each defence covers something real. None addresses the exercising body in the garment.
What Would Change This Analysis
Three studies would materially update the conclusion. Each is feasible. None is currently funded.
First: extension of the Harrad 2024 protocol to realistic carrier and conditions -- synthetic sweat as vehicle, 36 C skin-temperature hold, mechanical occlusion, and two-hour contact duration on a 3D human skin equivalent. If absorption values under these conditions fell below the methanol-carrier baseline, the directional claim weakens. If they matched or exceeded it, the transdermal-patch specification is confirmed. Neither outcome is known.
Second: a wearer serum-biomonitoring study measuring PFAA concentrations in regular compression-activewear users versus non-users, controlled for water and dietary exposure, on a dose-by-hours-by-surface-area gradient. If no user-versus-non-user difference emerged after control, the activewear pathway would not be attributable at population scale.
Third: zone-by-zone stratum corneum sampling -- tape-strip collection from skin under high-DWR panels versus low-DWR panels of the same garment after use. Differential fluorine loading would confirm the zone-overlap mechanism. Uniform loading would weaken it.
These three studies have not been run. That is a finding about where research funding goes.
The Levers
Tier 1 -- No-Cost / Low-Friction (for the garment already in the drawer):
- Change out of compression activewear immediately after exercise. Reduce occlusion-hours. Do not wear it as loungewear.
- Rinse the skin of high-contact zones -- lumbar, chest, inner thigh -- after exercise. Remove the residual carrier before continued absorption.
- Read claim language in the legal register, not the shopping register. "Does not use PFAS in products today" with vendor-offloaded testing is a compliance statement, not a measurement the consumer can trace. Treat unverified claims as unverified.
- Air-dry DWR-treated garments rather than tumble-drying at high heat. Accept fewer wash cycles where possible -- each cycle partitions more previously-bound fluorine toward the skin-contacting face.
Tier 2 -- Replacement by Material Specification (when replacing anyway):
- For compression base layers: organic cotton or merino wool with chrome-free dye processing and no DWR finish. These materials lose the water-beading feature. They retain thermal regulation and moisture-wicking function under different physics.
- For outer layers requiring water resistance: mechanically densified weaves (tightly woven ventile, high-thread-count cottons, waxed-wool textiles) achieve partial water resistance without fluorinated or silicone finish. Polyurethane-coated shells offer higher performance at lower dermal exposure than SFP-finished alternatives.
- For high-performance wet-weather use: the C0 fluorine-free DWR class delivers water repellency that requires more frequent reactivation through heat. This is a trade-off the consumer pays in maintenance frequency; it is not a zero-chemistry product.
- Avoid: any DWR-treated compression garment whose claim rests on "intentionally added" language, present-tense self-declaration, or vendor-delegated testing with undisclosed method and detection limit.
Every component of a multi-material garment -- fabric, finish, dye, elastane, trim -- must be separable and individually assessable against the standard that matters. This report does not recommend specific products by brand name.
264 Daltons. 214. 300. 314. The compression garment meets the specification. The body during exercise supplies the enhancer variables the pharmaceutical industry spent fifty years learning to optimise. The measurement that would tell the wearer what crosses -- from this garment, at this temperature, through this skin, in this sweat -- has not been funded.
The Magic Wand